Table 3.
Changes in Circulating IGFBP With Tesamorelin Treatment
Protein | Effect size (log2 fold change) | 95% CI of effect size | P value |
---|---|---|---|
IGFBP-1 | 0.64 | (0.18, 1.11) | 0.01 |
IGFBP-2 | −0.46 | (−0.71, −0.21) | 0.0007 |
IGFBP-3 | 0.24 | (0.01, 0.47) | 0.05 |
IGFBP-6 | −0.23 | (−0.44, −0.02) | 0.04 |
IGFBP-7 | 0.00 | (−0.23, 0.24) | 0.98 |
Effect size and P value for the time × randomization interaction in mixed effects modeling for continuous repeated measures in the entire study cohort (N = 61).